Home › Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk
 

Keywords :   


Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

2014-08-30 03:04:00| Biotech - Topix.net

Takeda Pharmaceuticals and Eli Lilly & Co lost a bid to overthrow a combined $9 billion punitive-damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.

Tags: risk award bid cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
01.07Union expected to call off Port Talbot strike action
01.07Mentorship in Motion
01.07Farm Progress America, July 1, 2024
01.07Mortgage rates hitting affordability - Nationwide
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
More »